Panjon Ltd.

20.30 +0.30 ▲1.5%

26 April 2024, 02:21:00 PM
Volume: 19,451

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panjon.in
Market Cap 32.38 Cr.
Enterprise Value(EV) 32.45 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.06 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 330.38 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 8.76 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.38 Calculated using Price: 20.89
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.55 Cr. 15,498,700 Shares
FaceValue 10
About Panjon Ltd.
The company manufactures and markets world class FMCG & Ayurveda formulations

Panjon Ltd. Delivery

Delivered Qty
Traded Qty

Panjon Ltd. Performance

1 Day
+1.50%
1 Week
+6.62%
1 Month
+18.92%
3 Month
+12.84%
6 Month
+56.15%
1 Year
+45.00%
2 Year
+13.41%
5 Year
10 Year

Panjon Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -17.68 2.23 0.71 0.74 0.84 -0.19 0.57 -28.17 6.2
Return on Capital Employed (%) -22.21 0.94 1.75 2.03 2.59 1.84 1.6 -24.99 1.2
Return on Assets (%) -15.33 2.11 0.68 0.7 0.78 -0.18 0.52 -25.77 5.94

Panjon Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 16 16 17 17 17 17 17 13 13 14
Non Curr. Liab. 1 0 0 0 0 1 0 0 -1 -1
Curr. Liab. 1 0 1 1 1 1 1 1 1 2
Minority Int.
Equity & Liab. 17 17 17 18 18 19 19 14 14 15
Non Curr. Assets 2 2 2 10 9 7 7 5 3 3
Curr. Assets 15 15 15 8 9 11 12 9 11 12
Misc. Exp. not W/O
Total Assets 17 17 17 18 18 19 19 14 14 15

Panjon Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 12 14 20 26 26 15 8 6 9
Other Income 0 0 1 0 0 0 0 0 0 0
Total Income 20 13 15 20 26 27 15 9 6 9
Total Expenditure -23 -12 -14 -20 -26 -26 -14 -12 -6 -9
PBIDT -3 0 0 0 1 1 1 -4 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 1 0 0 0 0 0 0 0 1
Exceptional Items -2
PAT -3 0 0 0 0 0 0 -4 1 0
Adjusted EPS -2 0 0 0 0 0 0 -3 1 0

Panjon Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -3 1 0 0 0 0 0 0 2 0
Cash Fr. Inv. 0 5 0 0 0 0 -1 0 0 0
Cash Fr. Finan. 3 -5 0 0 0 0 0 0 -1 0
Net Change 0 0 0 0 0 0 0 0 1 0
Cash & Cash Eqvt 0 1 0 0 0 1 0 0 1 1

Panjon Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03
Public 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Panjon Ltd. Announcements

Sat, 13 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under regulation 74(5) SEBI (D&P) Regulation 2015 for the quarter ended March 31 2024
Wed, 27 Mar 2024
Closure of Trading Window
THE TRADING WINDOW FOR DEALING IN THE SECURITIES OF THE COMPANY BY DESIGNATED PERSONS SHALL REMAIN CLOSED FROM MONDAY 01ST APRIL 2024 UNTIL 48 HRS AFTER THE ANNOUNCEMENT OF AUDITED FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER AND YEAR ENDED 31ST MARCH 2024.
Fri, 22 Mar 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Kothari

Panjon Ltd. Technical Scans

Thu, 25 Apr 2024
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Panjon Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,504.90 -1.0%
Cipla Ltd. 113,471.29 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,280.00 +1.0%
Divi's Laboratories Ltd. 101,959.84 4,001.45 +4.1%
Zydus Lifesciences Ltd. 95,944.41 948.50 -0.3%
Mankind Pharma Ltd. 95,926.91 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,273.55 -1.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-12 30.60 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,273.55 -1.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-12 4.38 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,273.55 -1.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,273.55 -1.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,273.55 -1.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,273.55 -1.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,273.55 -1.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,504.90 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,410.25 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,280.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,001.45 +4.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 948.50 -0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,392.05 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,273.55 -1.7%

Panjon Ltd. FAQ's

What is Panjon share price?

Can I buy Panjon shares now?

What is the Market Cap of Panjon?

What are the key metrics to analyse Panjon?

What is the 52 Week High and Low of Panjon?

What is the trend of Panjon share price?